Linked Life Data

17078059

Source:http://linkedlifedata.com/resource/pubmed/id/17078059

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2006-12-27
pubmed:abstractText
Between 4% and 14% of patients diagnosed with Parkinson's disease and entering clinical trials have normal presynaptic dopaminergic imaging. The effects of antiparkinsonian therapy have varied in these studies, and the consequences of stopping treatment are not reported. We present 11 patients who initially fulfilled diagnostic criteria and were treated for Parkinson's disease but in whom emerging diagnostic doubts led to antiparkinsonian therapy withdrawal, which was achieved without deterioration. Such cases represent a nondegenerative form of Parkinsonism, which does not benefit from dopaminergic therapy. Prospective vigilance regarding this category is of importance in clinical practice and clinical trials.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0885-3185
pubmed:author
pubmed:copyrightInfo
Copyright 2006 Movement Disorder Society.
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2247-50
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Successful antiparkinsonian medication withdrawal in patients with Parkinsonism and normal FP-CIT SPECT.
pubmed:affiliation
Department of Neurology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, United Kingdom. v.marshall@clinmed.gla.ac.uk
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study